The Startup Incubation and Innovation Centre (SIIC), the technology business incubator of the Indian Institute of Technology Kanpur (IIT-K), has signed a Memorandum of Understanding (MoU) with pharmaceutical company Boehringer Ingelheim India.

The MoU was signed in the presence of dignitaries from SIIC, IIT-K, and Boehringer Ingelheim India. Prof. Ankush Sharma, Professor-in-charge, Innovation and Incubation, IIT-K, and Prabhat Sinha, Director, Government and Public Affairs, Boehringer Ingelheim India, were the signing authorities for this MoU exchange.

The purpose of this collaboration is to extend support to nationally significant innovations developed at SIIC, with a specific emphasis on healthcare solutions that leverage technology to make a positive impact on patients' lives. The focus will be on socially beneficial innovations that can drive transformational change in the healthcare industry.

As a part of this collaboration, Boehringer Ingelheim will provide support to Lenek Technologies, one of the startups incubated at SIIC, IIT-K. Lenek Technologies aims to eradicate Tuberculosis (TB) by improving the screening process through its innovative handheld X-ray device, which has the potential to bring about a significant change in TB screening in areas where resources are limited.